首页> 中文期刊> 《中外医疗》 >急诊内科老年重症心力衰竭临床治疗分析

急诊内科老年重症心力衰竭临床治疗分析

         

摘要

Objective To observe the clinical treatment for elderly severe heart failure in the department of emergency medicine and discuss its treatment method. Methods 60 cases of patients admitted and treated in the department of emer-gency medicine from October 2014 to October 2015 were selected and divided into two groups with 30 cases in each, the control group were treated with conventional and basic method, the research group were treated with metoprolol on this ba-sis, and the treatment effects were compared and analyzed between the two groups. Results The total effective rate in the research group was obviously higher than that in the control group, (90.00%vs 60.00%), P<0.05; the proportion of the car-diac function improvement degree of grade I and grade II in the research group was obviously better than that in the control group, P<0.05. Conclusion Metoprolol and irbesartan and hydrochlorothiazide treatment on the basis of the conventional treatment for elderly patients with severe heart failure in the department of emergency medicine can have an obvious effect, which is worth promotion and application.%目的:对急诊内科老年重症心力衰竭临床治疗进行观察,探讨其治疗方法。方法方便选取该院急诊内科2014年10月—2015年10月间收治的患者60例。按照平均数字分配的法则将60例患者分作两组,其中对照组30例患者实施的治疗方案是常规基础治疗,研究组30例患者实施的治疗方案是在对照组治疗基础上联合美托洛尔,并对研究组与对照组患者的治疗成效进行比对分析。结果研究组患者的总有效率为90.00%,明显高于对照组的60.00%,P﹤0.05;研究组患者的心功能改善程度I级、II级患者比例明显优于对照组,P﹤0.05。结论急诊内科老年重症心力衰竭患者在接受常规治疗的基础上,配合美托洛尔及厄贝沙坦氢氯噻嗪治疗能够产生显著的效果,值得推广应用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号